Clinical Trial Update: Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the blood lipid-lowering effect of Ecklonia cava extract in adults with hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Ecklonia cava extract (Ecklonia cava extract)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Hypercholesterolemia | Phase 2, Phase 3 | Status: COMPLETED